참고문헌 (46)

1. 10.1211/jpp.59.7.0012 1) Arruzazabala ML, Molina V, Mas R, Carbajal D, Marrero D, Gonzalez V, Rodriguez E. Effects of coconut oil on testosterone-induced prostatic hyperplasia in Sprague-Dawley rats. J. Pharm. Pharmacol. , 59 , 995-999 (2007). 

   상세보기

2. 10.1016/j.fitote.2003.12.016 2) Caballero SM, Fernandez CC, Perez-Fernandez R. Effect of an integral suspension of Lepidium latifolium on prostate hyperplasia in rats. Fitoterapia , 75 , 187-191 (2004). 

   상세보기

3. 3) Barkin J. Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management. Can. J. Urol. , 18 (Suppl.), 14-19 (2011). 

4. 10.1677/ERC-09-0070 4) Mizokami A, Koh E, Izumi K, Narimoto K, Takeda M, Honma S, Dai J, Keller ET, Namiki M. Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone. Endocr. Relat. Cancer , 16 , 1139-1155 (2009). 

   상세보기

5. 10.1111/j.1464-410X.2010.09699.x 5) Descazeaud A, Weinbreck N, Robert G, Vacherot F, Abbou CC, Labrousse F, Allory Y, Rubin MA, De la Taille A. Transforming growth factor beta-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation. BJU Int. , 108 (2b), E23-E28 (2011). 

   상세보기

6. 10.1210/en.2003-1716 6) Wadsworth TL, Carroll JM, Mallinson RA, Roberts CT Jr, Roselli CE. Saw palmetto extract suppresses insulin-like growth factor-I signaling and induces stress-activated protein kinase/c-Jun N-terminal kinase phosphorylation in human prostate epithelial cells. Endocrinology , 145 , 3205-3214 (2004). 

   상세보기

7. 10.1016/j.diff.2011.04.004 7) Wang Z, Olumi AF. Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia. Differentiation , 82 , 261-271 (2011). 

   상세보기

8. 10.1101/gad.12.22.3499 8) Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. , 12 , 3499-3511 (1998). 

   상세보기

9. 10.1074/jbc.273.45.29864 9) Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN, Rosen N. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. , 273 , 29864-29872 (1998). 

   상세보기

10. 10) Andriole G, Bruchovsky N, Chung LW, Matsumoto AM, Rittmaster R, Roehrborn C, Russell D, Tindall D. Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia. J. Urol. , 172 , 1399-1403 (2004). 

11. 10.2147/CIA.S4102 11) Miller J, Tarter TH. Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate. Clin. Interv. Aging , 4 , 251-258 (2009). 

    

12. 10.1016/S0090-4295(03)00045-1 12) Carson C 3rd, Rittmaster R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology , 61 (Suppl. 1), 2-7 (2003). 

    상세보기

13. 10.1016/S0092-8674(00)80405-5 13) Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell , 91 , 231-241 (1997). 

    상세보기

14. 10.3892/ol.2015.3218 14) Zheng D, Zhu G, Liao S, Yi W, Luo G, He J, Pei Z, Li G, Zhou Y. Dysregulation of the PI3K/Akt signaling pathway affects cell cycle and apoptosis of side population cells in nasopharyngeal carcinoma. Oncol. Lett , 10 , 182-188 (2015). 

    상세보기

15. 15) Sahu J, Patel PK, Dubey B. Quisqualis indica Linn.: a review of its medicinal properties. Int. J. Pharm Phytopharmacol. Res. , 1 , 313-321 (2012). 

16. 10.1002/jccs.199700025 16) Lin TC, Ma YT, Wu J, Hsu FL. Tannins and related compounds from Quisqualis indica . J. Chin. Chem. Soc. , 44 , 151-155 (1997). 

    상세보기

17. 17) Kambar Y, Asha MM, Chaithra M, Prashith KTR. Antibacterial activity of leaf and flower extract of Quisqualis indica Linn. against clinical isolates of Staphylococcus aureus. Research J. Sci. Tech. , 6 , 23-24 (2014). 

18. 18) Singh N, Khatri P, Samantha KC, Damor R. Antipyretic activity of methanolic extract of leaves of Quisqualis indica Linn. Int. J. Pharm. Res. Dev , 2 , 122-126 (2010). 

19. 10.3329/dujps.v8i2.6034 19) Kaisar MA, Islam MR, Rahman MS, Hossain MK, Rashid MA. Total phenolic content, free radical scavenging activity and reducing power of Quisqualis indica Linn. Dhaka. Univ. J. Pharm. Sci , 8 , 173-175 (2009). 

    상세보기

20. 20) Sagrawat H, Khan MY. Immunomodulatory plants: a phytopharmacological review. Pharmacogn. Rev. , 1 , 248-260 (2007). 

21. 21) Jahan FN, Rahman MS, Rahman MM, Gibbons S, Masud MM, Sadhu SK, Hossain M, Hasan CM, Rashid MA. Diphenylpropanoids from Quisqualis indica Linn. and their anti-staphylococcal activity. Lat. Am. J. Pharm. , 28 , 279-283 (2009). 

22. 10.1016/0024-3205(81)90669-X 22) Fernstrom MH, Fernstrom JD. Rapid measurement of free amino acids in serum and CSF using high-performance liquid chromatography. Life Sci. , 29 , 2119-2130 (1981). 

    상세보기

23. 23) HKCMMS. “Hong Kong Chinese Materia Medica Standards 2015.”: ？http://www.cmd.gov.hk/hkcmms/vol6/main.html？, cited 29 March, 2017. 

24. 10.1016/j.jep.2017.07.004 24) Jiang R, Xu XH, Wang K, Yang XZ, Bi YF, Yan Y, Liu JZ, Chen XN, Wang ZZ, Guo XL, Zhao DQ, Sun LW. Ethyl acetate extract from Panax ginseng CA Meyer and its main constituents inhibit α-melanocyte-stimulating hormone-induced melanogenesis by suppressing oxidative stress in B16 mouse melanoma cells. J. Ethnopharmacol. , 208 , 149-156 (2017). 

    상세보기

25. 25) Patil AA, Veeresh B, Yadav A. Combination of lauric acid and myristic acid prevents benign prostatic hyperplasia (BPH) symptoms in animal model. Afr. J. Pharm. Pharmacol , 10 , 101-106 (2016). 

26. 10.1016/S0083-6729(01)62005-3 26) Lamb DJ, Weigel NL, Marcelli M. Androgen receptors and their biology. Vitam. Horm. , 62 , 199-230 (2001). 

    

27. 10.1002/pros.22696 27) Chhipa RR, Halim D, Cheng J, Zhang HY, Mohler JL, Ip C, Wu Y. The direct inhibitory effect of dutasteride or finasteride on androgen receptor activity is cell line specific. Prostate , 73 , 1483-1494 (2013). 

    상세보기

28. 10.1002/pros.10170 28) Marinese D, Patel R, Walden PD. Mechanistic investigation of the adrenergic induction of ventral prostate hyperplasia in mice. Prostate , 54 , 230-237 (2003). 

    상세보기

29. 10.1038/nrc839 29) Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer , 2 , 489-501 (2002). 

    상세보기

30. 10.1016/j.ejphar.2009.09.037 30) Veeresh Babu SV, Veeresh B, Patil AA, Warke YB. Lauric acid and myristic acid prevent testosterone induced prostatic hyperplasia in rats. Eur. J. Pharmacol. , 626 , 262-265 (2010). 

    상세보기

31. 10.2165/00126839-200607040-00003 31) Arruzazabala ML, Mas R, Molina V, Noa M, Carbajal D, Mendoza N. Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in rats. Drugs R D. , 7 , 233-241 (2006). 

    상세보기

32. 10.1016/j.mcna.2010.08.013 32) Roehrborn CG. Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Med. Clin. North Am. , 95 , 87-100 (2011). 

    상세보기

33. 10.1186/1472-6882-12-48 33) Shin IS, Lee MY, Ha HK, Seo CS, Shin HK. Inhibitory effect of Yukmijihwang-tang, a traditional herbal formula against testosterone-induced benign prostatic hyperplasia in rats. BMC Complement. Altern. Med. , 12 , 48 (2012). 

    상세보기

34. 10.2174/138161206776056010 34) Tarter TH, Vaughan ED Jr. Inhibitors of 5alpha-reductase in the treatment of benign prostatic hyperplasia. Curr. Pharm. Des. , 12 , 775-783 (2006). 

    상세보기

35. 10.1016/j.steroids.2009.10.005 35) Aggarwal S, Thareja S, Verma A, Bhardwai TR, Kumar M. An overview on 5alpha-reductase inhibitors. Steroids , 75 , 109-153 (2010). 

    상세보기

36. 36) Lobaccaro JM, Boudan C, lechevallier E, Mottet N, Rebillard X, Lumbroso S, Gibelin B, Sultan C. Effect of finasteride (Proscar) on the proliferation of cultured epithelial and stromal cells from normal and hyperplastic human prostates. Cell. Mol. Biol. , 42 , 511-518 (1996). 

37. 10.25011/cim.v31i1.3136 37) Zhong W, peng J, He H, Wu D, Han Z, Bi X, Dai Q. Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia. Clin. Invest. Med. , 31 , E8-E15 (2008). 

    

38. 10.1038/aja.2011.166 38) Lee MY, Shin IS, Seo CS, Lee NH, Ha HK, Son JK, Shin HK. Effects of Melandrium firmum methanolic extract on testosterone-induced benign prostatic hyperplasia in Wistar rats. Asian J. Androl. , 14 , 320-324 (2012). 

    상세보기

39. 10.1155/2016/1428923 39) Park E, Lee MY, Jeon WY, Lee N, Seo CS, Shin HK. Inhibitory effect of Yongdamsagan-tang water extract, a traditional herbal formula, on testosterone-induced benign prostatic hyperplasia in rats. Evid. Based Complement. Alternat. Med. , 2016 , 1428923 (2016). 

    상세보기

40. 40) Angelucci C, Lacopino F, Lama G, Zelano G, Gianesini G, Sica G, Bono AV. Reverse transcriptase-PCR analysis of apoptosis-regulating gene expression in human benign prostatic hyperplasia. Anticancer Res. , 25 (6B), 3937-3941 (2005). 

41. 10.3390/ijms17081311 41) Minutoli L, Rinaldi M, Marini H, Irrera N, Crea G, Lorenzini C, Puzzolo D, Valenti A, Pisani A, Adamo EB, Altavilla D, Squadrito F, Micali A. Apoptotic pathways linked to endocrine system as potential therapeutic targets for benign prostatic hyperplasia. Int. J. Mol. Sci. , 17 , E1311 (2016). 

    상세보기

42. 10.1177/1535370215590823 42) Chung KS, An HJ, Cheon SY, Kwon KR, Lee KH. Bee venom suppresses testosterone-induced benign prostatic hyperplasia by regulating the inflammatory response and apoptosis. Exp. Biol. Med. (Maywood), 240 , 1656-1663 (2015). 

    상세보기

43. 10.1002/ptr.5637 43) Chung KS, Shin SJ, Lee NY, Cheon SY, Park W, Sun SH, An HJ. Anti-proliferation effects of garlic ( Allium sativum L.) on the progression of benign prostatic hyperplasia. Phytother. Res. , 30 , 1197-1203 (2016). 

    상세보기

44. 10.1006/excr.1999.4690 44) Kandel ES, Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res. , 253 , 210-229 (1999). 

    상세보기

45. 10.1517/14728214.11.1.111 45) Bullock TL, Andriole GL Jr. Emerging drug therapies for benign prostatic hyperplasia. Expert Opin. Emerg. Drugs , 11 , 111-123 (2006). 

    상세보기

46. 46) Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML. Adverse side effects of 5alpha-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients. J. Sex. Med. , 8 , 872-884 (2011).